Roberts E, Cook G A, Walsworth-Bell J P, Barrow S
North West Surveys and Research, Manchester Health Authority, United Kingdom.
J Med Screen. 1995;2(2):102-4. doi: 10.1177/096914139500200210.
To examine the efficacy of cytopathology laboratories in monitoring action following an abnormal cervical smear.
11 screening laboratories serving 19 districts in the former North Western region of the United Kingdom.
944 validated cases were identified at 11 laboratories. The screening history for each abnormal smear was obtained from the screening laboratory and compared with the records from the relevant family health services authority (FHSA) database.
Laboratories held complete follow up records in 740 (78.4%) cases; the FHSA records extended this to 910 (96.4%) cases. Poor communication was the main problem; computerisation was not necessary to improve fail-safe procedures.
Audit of fail-safe procedures is a valuable purchasing tool, identifying weaknesses and strengths, setting and maintaining standards.
研究细胞病理学实验室在监测宫颈涂片异常后的行动效果。
为英国前西北地区19个区服务的11个筛查实验室。
在11个实验室识别出944例经过验证的病例。从筛查实验室获取每个异常涂片的筛查历史，并与相关家庭健康服务机构（FHSA）数据库的记录进行比较。
实验室保存了740例（78.4%）病例的完整随访记录；FHSA的记录将这一比例扩大到910例（96.4%）。沟通不畅是主要问题；计算机化对于改进故障安全程序并非必要。
对故障安全程序的审核是一种有价值的采购工具，可识别弱点和优势，设定并维持标准。
